COMP <GO>
ARMK vs PG // ALTMAN Z-SCORE & DEBT/EQUITY
Aramark (NYSE) VS. Procter & Gamble Company (The) (NYSE) • 15-METRIC TALLY: ARMK 3
— PG 12
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: PG
LAST: $53.96 (-3.68%) • MKT CAP: $14.77B
balance-sheet
1.98
LAST: $161.57 (+0.61%) • MKT CAP: $372.21B
balance-sheet
5.59
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ARMK VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ARMK | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 51.20% | -10.20 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.40% | 25.40% | -14.00 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 18.0x | 16.2x | +1.80 | PG | /valuation <GO> |
| Free Cash Flow Yield | 1.26% | 3.77% | -2.51 | PG | /fcf-yield <GO> |
| Operating Margin | 19.10% | 24.30% | -5.20 | PG | /operating-margins <GO> |
| Net Profit Margin | 7.90% | 19.00% | -11.10 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | 4.40% | 0.30% | +4.10 | ARMK | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.75% | 2.65% | -1.90 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 1.98 | 5.59 | -3.61 | PG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | ARMK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.60% | 6.50% | +0.10 | PG | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 43.5 | 62.7 | -19.13 | PG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.91 | 0.87 | +0.04 | ARMK | /macro-sensitivity <GO> |
| Forward P/E Multiple | 42.0x | 21.7x | +20.30 | PG | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $14.77B | $372.21B | -$357.44B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ARMK REV | PG REV | ARMK GROSS % | PG GROSS % | ARMK FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $84.28B | — | 51.2% | $365.6M | $14.04B |
| FY 2024 | $0 | $84.04B | — | 51.4% | $294.0M | $16.52B |
| FY 2023 | $0 | $82.01B | — | 44.0% | $766.4M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ARMK // BETA 0.91
PG // BETA 0.87